FX-909, a first-in-class investigational oral small molecule inhibitor of peroxisome proliferator-activated receptor gamma (PPARG), showed early signs of clinical benefit in patients with advanced ...
Patients with early-stage bladder cancer are often able to maintain their usual routines. Some may experience urinary ...
SurvivorNet on MSN
Drug combination offers much-needed alternative for bladder cancer patients who can’t tolerate chemo
The VOLGA trial was the first to combine two immune checkpoint inhibitors with a targeted therapy in the perioperative ...
Before the discovery of newer options and combinations, chemotherapy that included platinum medications like cisplatin or carboplatin was the first choice, says Christopher Wee, MD, a genitourinary ...
A new treatment for advanced bladder cancer which doubles survival time has been approved for NHS use. The treatment for advanced bladder cancer had not significantly changed since the 1980s. Now, ...
Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, muscle-invasive bladder cancer, according to results of a new Phase III randomized trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results